Europe Point-of-Care Molecular Diagnostics Market- Global Drivers, Opportunities, Trends, and Forecasts to 2028
Market Introduction
Point-of-care molecular diagnostics include portable devices, and
assays & kits used to detect and diagnose diseases in human samples, such
as throat swab, blood, serum, and stool. Molecular diagnostics are shifting
from centralized laboratories to decentralized point-of-care molecular testing.
Due to its simplicity, convenience, rapid turnaround time, and potential to
improve patient outcomes, POCT is rapidly gaining traction.
Moreover, the growing demand for specific viral detection methods
that consume less time for timely infection control is expected to bolster the
market growth during the forecast period.
๐ ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐
๐๐๐ฆ๐ฉ๐ฅ๐
๐๐๐
๐๐จ๐ฉ๐ฒ@
https://www.businessmarketinsights.com/sample/TIPRE00026190
In Europe, currently, the UK and Russia are the hardest-hit
countries by the COVID-19 pandemic, followed by France, Spain, Italy, and
Germany. The implementation of drastic measures and travel restrictions,
including closing the borders, impacted the import and export of products,
especially in the first half of 2020. The continuous spread of the disease has
led to an elevated demand for advanced diagnostic solutions in Europe, thus
boosting the adoption of point-of-care molecular diagnostic kits. Moreover,
uninterrupted investments and business activities by industry players are also
boosting the point-of-care molecular diagnostic market growth. In 2020,
European Medicines Agency (EMA) approved ~97 medicines for the marketing
authorization, of which 39 were novel drugs. In October 2020, Eurofins
introduced PCR-based COVID-19 diagnostic tests with at-home, self-sampling
options, in the for European market. In January 2020, European Union (EU)
commission announced an emergency call, through which it awarded US$ 55.64
million to 18 research projects. Among these, 3 of the projects are receiving a
total of US$ 7.39 million to develop effective, rapid point-of-care diagnostics.
๐๐
๐ฎ๐ฅ๐ฅ
๐๐๐ฉ๐จ๐ซ๐ญ
๐๐ข๐ง๐ค
@ https://www.businessmarketinsights.com/reports/europe-point-of-care-molecular-diagnostics-market
๐๐ก๐ ๐๐ข๐ฌ๐ญ
๐จ๐
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
bioMรฉrieux SA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Enzo Biochem, Inc.
Abbott
binx health, Inc.
Meridian BioScience, Inc.
Biocartis
Quidel Corporation
Bio-Rad Laboratories, Inc
·
Segments
Covered
By Product & Services
- Assays
and Kits
- Instruments
- Services
and Software
By Technology
- PCR
- Isothermal
Nucleic Acid Amplification Technology
- Other
Technologies
By Application
- Infectious
Diseases
- Oncology
- Hematology
- Prenatal
Testing
- Endocrinology
- Other
Applications
By End User
- Hospitals
and Clinics
- Diagnostic
Laboratories
- Research
and Academic Institutes
Major Sources and Companies: A
Competitive Landscape
The European POC MDx market is
characterized by a mix of established multinational corporations and innovative
startups.
- Major Companies:
- The listed companies represent a diverse range of
expertise in molecular diagnostics, including:
- bioMรฉrieux SA: A leader in microbiology and
infectious disease diagnostics.
- F. Hoffmann-La Roche Ltd.: A global healthcare giant
with a strong presence in molecular diagnostics.
- Danaher Corporation: A diversified technology company
with a portfolio of diagnostic solutions.
- Abbott: a large diversified medical company.
- The inclusion of companies like binx health, Inc.
highlights the growing importance of innovative startups in the POC MDx
market.
- Sources of Information:
- The reliance on company websites, annual reports,
financial reports, government documents, and statistical databases
underscores the importance of both primary and secondary research in
market analysis.
- This variety of sources helps to give a complete and
accurate view of the market.
Key Considerations:
- The market is dynamic, and the relative share of each
segment may shift over time.
- Technological advancements and evolving healthcare
needs will continue to shape the market landscape.
- Regulatory changes can also have a very large impact on
this market.
By understanding these key market
segments and the competitive landscape, stakeholders can gain valuable insights
into the opportunities and challenges in the European POC MDx market.
Comments
Post a Comment